Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Houda Bahig

Showing results (121-130 of 134) with videos related to

Pageof 14
Sort By:
Cancer|February 13, 2019
Usefulness of surveillance imaging in patients with head and neck cancer who are treated with definitive radiotherapySweet Ping Ng, Courtney Pollard, Joel Berends, et al.
International Journal of Radiation Oncology, Biology, Physics|September 5, 2025
Dosimetric Outcomes of SBRT to Ultra-central Lung Tumors: Lessons from the SUNSET trialRohan Salunkhe, David A Palma, Andrew Warner, et al.
JAMA Otolaryngology-- Head & Neck Surgery|July 9, 2023
Oncologic Significance of Therapeutic Delays in Patients With Oral Cavity CancerGabriel S Dayan, Houda Bahig, Stephanie Johnson-Obaseki, et al.
European Journal of Cancer (Oxford, England : 1990)|November 26, 2020
Durvalumab therapy following chemoradiation compared with a historical cohort treated with chemoradiation alone in patients with stage III non-small cell lung cancer: A real-world multicentre studyAntoine Desilets, Félix Blanc-Durand, Sally Lau, et al.
BMC Palliative Care|September 7, 2024
A randomized phase III trial of stereotactic ablative radiotherapy for patients with up to 10 oligometastases and a synchronous primary tumor (SABR-SYNC): study protocolDavid A Palma, Meredith E Giuliani, Rohann J M Correa, et al.
JAMA Otolaryngology-- Head & Neck Surgery|May 8, 2025
A Proposal for HPV-Associated Oropharyngeal Carcinoma in the Ninth Edition Clinical TNM ClassificationShao Hui Huang, Jie Su, Shlomo A Koyfman, et al.
BMC Cancer|September 21, 2018
Predicting treatment Response based on Dual assessment of magnetic resonance Imaging kinetics and Circulating Tumor cells in patients with Head and Neck cancer (PREDICT-HN): matching 'liquid biopsy' and quantitative tumor modelingSweet Ping Ng, Houda Bahig, Jihong Wang, et al.
Journal of Otolaryngology - Head & Neck Surgery = Le Journal D'Oto-Rhino-Laryngologie Et De Chirurgie Cervico-Faciale|August 22, 2025
Oral Cavity Squamous Cell Carcinoma in Young Patients: A Multi-Institutional Study of the Canadian Head & Neck Collaborative Research InitiativeXinyuan Hong, Alexandra E Quimby, Dorsa Mavedatnia, et al.
Medrxiv : the Preprint Server for Health Sciences|May 19, 2023
Longitudinal diffusion and volumetric kinetics of head and neck cancer magnetic resonance on a 1.5T MR-Linear accelerator hybrid system: A prospective R-IDEAL Stage 2a imaging biomarker characterization/ pre-qualification studyDina M El-Habashy, Kareem A Wahid, Renjie He, et al.
BMC Cancer|February 3, 2024
Single vs. multiple fraction non-inferiority trial of stereotactic ablative radiotherapy for the comprehensive treatment of oligo-metastases/progression: SIMPLIFY-SABR-COMETRobert Olson, Hadassah Abraham, Curtis Leclerc, et al.
Pageof 14

Showing results (121-130 of 134) with videos related to

Sort By:
Pageof 14
Cancer|February 13, 2019
Usefulness of surveillance imaging in patients with head and neck cancer who are treated with definitive radiotherapySweet Ping Ng, Courtney Pollard, Joel Berends, et al.
International Journal of Radiation Oncology, Biology, Physics|September 5, 2025
Dosimetric Outcomes of SBRT to Ultra-central Lung Tumors: Lessons from the SUNSET trialRohan Salunkhe, David A Palma, Andrew Warner, et al.
JAMA Otolaryngology-- Head & Neck Surgery|July 9, 2023
Oncologic Significance of Therapeutic Delays in Patients With Oral Cavity CancerGabriel S Dayan, Houda Bahig, Stephanie Johnson-Obaseki, et al.
European Journal of Cancer (Oxford, England : 1990)|November 26, 2020
Durvalumab therapy following chemoradiation compared with a historical cohort treated with chemoradiation alone in patients with stage III non-small cell lung cancer: A real-world multicentre studyAntoine Desilets, Félix Blanc-Durand, Sally Lau, et al.
BMC Palliative Care|September 7, 2024
A randomized phase III trial of stereotactic ablative radiotherapy for patients with up to 10 oligometastases and a synchronous primary tumor (SABR-SYNC): study protocolDavid A Palma, Meredith E Giuliani, Rohann J M Correa, et al.
JAMA Otolaryngology-- Head & Neck Surgery|May 8, 2025
A Proposal for HPV-Associated Oropharyngeal Carcinoma in the Ninth Edition Clinical TNM ClassificationShao Hui Huang, Jie Su, Shlomo A Koyfman, et al.
BMC Cancer|September 21, 2018
Predicting treatment Response based on Dual assessment of magnetic resonance Imaging kinetics and Circulating Tumor cells in patients with Head and Neck cancer (PREDICT-HN): matching 'liquid biopsy' and quantitative tumor modelingSweet Ping Ng, Houda Bahig, Jihong Wang, et al.
Journal of Otolaryngology - Head & Neck Surgery = Le Journal D'Oto-Rhino-Laryngologie Et De Chirurgie Cervico-Faciale|August 22, 2025
Oral Cavity Squamous Cell Carcinoma in Young Patients: A Multi-Institutional Study of the Canadian Head & Neck Collaborative Research InitiativeXinyuan Hong, Alexandra E Quimby, Dorsa Mavedatnia, et al.
Medrxiv : the Preprint Server for Health Sciences|May 19, 2023
Longitudinal diffusion and volumetric kinetics of head and neck cancer magnetic resonance on a 1.5T MR-Linear accelerator hybrid system: A prospective R-IDEAL Stage 2a imaging biomarker characterization/ pre-qualification studyDina M El-Habashy, Kareem A Wahid, Renjie He, et al.
BMC Cancer|February 3, 2024
Single vs. multiple fraction non-inferiority trial of stereotactic ablative radiotherapy for the comprehensive treatment of oligo-metastases/progression: SIMPLIFY-SABR-COMETRobert Olson, Hadassah Abraham, Curtis Leclerc, et al.
Pageof 14